Diversity of microbial species implicated in keratitis: A review

Open Ophthalmology Journal

Volumn 6, Issue , 2012, Pages 110-124

  Karsten, Elisabeth ^a   Watson, Stephanie Lousie ^a,b   Foster, Leslie John Ray ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acanthamoeba; Amoebic keratitis; Candida; Fusarium; Herpetic keratitis; HSV 1; Microbial keratitis; Mycotic keratitis; Staphylococcus

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CHLORHEXIDINE; CIPROFLOXACIN; DIAMIDINE DERIVATIVE; ECONAZOLE; FLUCONAZOLE; NATAMYCIN; OFLOXACIN; POLY(HEXAMETHYLENEBIGUANIDE); QUINOLINE DERIVED ANTIINFECTIVE AGENT; VORICONAZOLE; AMPHOTERICIN; VIRULENCE FACTOR;

AMEBIC INFECTION; ASCOMYCETES; BACTERIAL KERATITIS; BACTERIUM IDENTIFICATION; BASIDIOMYCETES; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FUNGUS IDENTIFICATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HERPES SIMPLEX KERATITIS; HERPES VIRUS; HUMAN; INFECTION RISK; KERATITIS; KERATOMYCOSIS; MICROBIAL DIVERSITY; MYXOGASTRIA; NONHUMAN; OOMYCETES; PARAMYXOVIRUS; PARASITE IDENTIFICATION; POXVIRUS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SPECIES COMPARISON; SPECIES DISTRIBUTION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VIRUS IDENTIFICATION; VIRUS KERATITIS; ZYGOMYCETES; ACTINOBACTERIA; AMOEBIC KERATITIS; BACTEROIDES; FIRMICUTES; HYPOPYON; KERATOPLASTY; PROTEOBACTERIA; RISK FACTOR; WOUND HEALING;

EID: 84871645643     PISSN: None     EISSN: 18743641     Source Type: Journal    
DOI: 10.2174/1874364101206010110     Document Type: Review

References (167)

1. Shukla PK, Kumar M, Keshava GB. Mycotic keratitis: an overview of diagnosis and therapy. Mycoses 2008; 51(3): 183-199.
2. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology 2006; 113(1): 109-116.
3. Liesegang TJ. Contact lens-related microbial keratitis: part i: epidemiology. Cornea 1997; 16(2): 125-131.
4. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001; 79(3): 214-221.
5. Stapleton F, Keay LJ, Sanfilippo PG, Katiyar S, Edwards KP, Naduvilath T. Relationship between climate, disease severity, and causative organism for contact lens-associated microbial keratitis in Australia. Am J Ophthalmol 2007; 144(5): 690-698.
6. Shah A, Sachdev A, Coggon D, Hossain P. Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature. Br J Ophthalmol 2011; 95(6): 762-767.
7. Asbell PA, Colby KA, Deng S, et al. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol 2008; 145(6): 951-958.
8. Alonso MJ, Sanchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol 2003; 55(11): 1451-1463.
9. Thomas PA. Mycotic keratitis--an underestimated mycosis. J Med Vet Mycol 1994; 32(4): 235-256.
10. Dahlgren MA, Lingappan A, Wilhelmus KR. The clinical diagnosis of microbial keratitis. Am J Ophthalmol 2007; 143(6): 940-944.
11. Thomas PA. Fungal infections of the cornea. Eye 2003; 17(8): 852-862.
12. Sun RL, Jones DB, Wilhelmus KR. Clinical characteristics and outcome of Candida keratitis. Am J Ophthalmol 2007; 143(6): 1043-1045.
13. Wang L, Sun S, Jing Y, Han L, Zhang H, Yue J. Spectrum of fungal keratitis in central China. Clin Experiment Ophthalmol 2009; 37(8): 763-771.
14. Seal DV, Kirkness CM, Bennett HG, Peterson M. Population-based cohort study of microbial keratitis in Scotland: incidence and features. Cont Lens Anterior Eye 1999; 22(2): 49-57.
15. Rautaraya B, Sharma S, Kar S, Das S, Sahu SK. Diagnosis and treatment outcome of mycotic keratitis at a tertiary eye care center in eastern India. BMC Ophthalmol 2011, 11:39.
16. Garg P, Gopinathan U, Choudhary K, Rao GN. Keratomycosis: clinical and microbiologic experience with dematiaceous fungi. Ophthalmology 2000; 107(3): 574-580.
17. Forster RK, Rebell G. Therapeutic surgery in failures of medical treatment for fungal keratitis. Br J Ophthalmol 1975; 59(7): 366-371.
18. Tanure MA, Cohen EJ, Sudesh S, Rapuano CJ, Laibson PR. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 2000; 19(3): 307-312.
19. O'Day DM. Selection of appropriate antifungal therapy. Cornea 1987; 6(4): 238-245.
20. Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivasan M. Risk factors for treatment outcome in fungal keratitis. Ophthalmology 2006; 113(4): 526-530.
21. Galarreta DJ, Tuft SJ, Ramsay A, Dart JK. Fungal keratitis in London: microbiological and clinical evaluation. Cornea 2007; 26(9): 1082-1086.
22. Yilmaz S, Maden A. Severe fungal keratitis treated with subconjunctival fluconazole. Am J Ophthalmol 2005; 140(3): 454-458.
23. Prajna NV, Mascarenhas J, Krishnan T, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol 2010; 128(6): 672-678.
24. Ritterband DC, Seedor JA, Shah MK, Koplin RS, McCormick SA. Fungal keratitis at the new york eye and ear infirmary. Cornea 2006; 25(3): 264-267.
25. Kalavathy CM, Parmar P, Kaliamurthy J, et al. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea 2005; 24(4): 449-452.
26. Manzouri B, Vafidis GC, Wyse RK. Pharmacotherapy of fungal eye infections. Expert Opin Pharmacother 2001; 2(11): 1849-1857.
27. Sengupta S, Rajan S, Reddy PR, et al. Comparative study on the incidence and outcomes of pigmented versus non pigmented keratomycosis. Indian J Ophthalmol 2011; 59(4): 291-296.
28. Kaur IP, Kakkar S. Topical delivery of antifungal agents. Expert Opin Drug Deliv 2010; 7(11): 1303-1327.
29. Mahdy RA, Nada WM, Wageh MM, Kader MA, Saleh MM, Alswad MM. Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis. Cutan Ocul Toxicol 2010; 29(3): 193-197.
30. Shah KB, Wu TG, Wilhelmus KR, Jones DB. Activity of voriconazole against corneal isolates of Scedosporium apiospermum. Cornea 2003; 22(1): 33-36.
31. Ozbek Z, Kang S, Sivalingam J, Rapuano CJ, Cohen EJ, Hammersmith KM. Voriconazole in the management of Alternaria keratitis. Cornea 2006; 25(2): 242-244.
32. Xie L, Zhong W, Shi W, Sun S. Spectrum of fungal keratitis in north China. Ophthalmology 2006; 113(11): 1943-1948.
33. Saha R, Das S. Mycological profile of infectious Keratitis from Delhi. Indian J Med Res 2006; 123(2): 159-164.
34. Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 2003; 87(7): 834-838.
35. Titiyal JS, Negi S, Anand A, Tandon R, Sharma N, Vajpayee RB. Risk factors for perforation in microbial corneal ulcers in north India. Br J Ophthalmol 2006; 90(6): 686-689.
36. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res 2004; 23(1): 1-30.
37. Kaye S, Tuft S, Neal T, et al. Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis. Invest Ophthalmol Vis Sci 2010; 51(1): 362-368.
38. Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res 1993; 12(5): 461-467.
39. Bower KS, Kowalski RP, Gordon YJ. Fluoroquinolones in the treatment of bacterial keratitis. Am J Ophthalmol 1996; 121(6): 712-715.
40. Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 2001; 85(7): 842-847.
41. Jhanji V, Sharma N, Satpathy G, Titiyal J. Fourth-generation fluoroquinolone-resistant bacterial keratitis. J Cataract Refract Surg 2007; 33(8): 1488-1489.
42. Shalchi Z, Gurbaxani A, Baker M, Nash J. Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United kingdom. Ophthalmology 2011; 118(11): 2161-2165.
43. Reviglio VE, Hakim MA, Song JK, O'Brien TP. Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea. BMC Ophthalmol 2003; 3: 10.
44. McLeod SD, LaBree LD, Tayyanipour R, Flowers CW, Lee PP, McDonnell PJ. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology 1995; 102(12): 1943-1948.
45. Lorian V, Burns L. Predictive value of susceptibility tests for the outcome of antibacterial therapy. J Antimicrob Chemother 1990; 25(1): 175-181.
46. Foster LJ, Thomson K, Marcal H, Butt J, Watson SL, Wakefield D. Chitosan-vancomysin composite biomaterial as a laser activated surgical adhesive with regional antimicrobial activity. Biomacromolecules 2010; 11(12): 3563-3570.
47. Tuft SJ, Tullo AB. Fungal keratitis in the United Kingdom 2003-2005. Eye 2009; 23(6): 1308-1313.
48. da Rocha-Azevedo B, Tanowitz HB, Marciano-Cabral F. Diagnosis of infections caused by pathogenic free-living amoebae. Interdiscip Perspect Infect Dis 2009; 2009: 251406.
49. Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD. Amoebic infection of the eye. Lancet 1974; 2(7896): 1537-1540.
50. Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 2004; 34(9): 1001-1027.
51. Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 2009; 148(4): 487-499 e482.
52. Bennett HG, Hay J, Kirkness CM, Seal DV, Devonshire P. Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers. Br J Ophthalmol 1998; 82(2): 137-145.
53. Ozkoc S, Tuncay S, Delibas SB, et al. Identification of Acanthamoeba genotype T4 and Paravahlkampfia sp. from two clinical samples. J Med Microbiol 2008; 57(Pt 3): 392-396.
54. Kennedy SM, Devine P, Hurley C, Ooi YS, Collum LM. Corneal infection associated with Hartmannella vermiformis in contact-lens wearer. Lancet 1995; 346(8975): 637-638.
55. Berger ST, Mondino BJ, Hoft RH, et al. Successful medical management of Acanthamoeba keratitis. Am J Ophthalmol 1990; 110(4): 395-403.
56. Kosrirukvongs P, Wanachiwanawin D, Visvesvara GS. Treatment of acanthamoeba keratitis with chlorhexidine. Ophthalmology 1999; 106(4): 798-802.
57. Narasimhan S, Madhavan HN, Ka LT. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine. Cornea 2002; 21(2): 203-205.
58. Moore MB, McCulley JP, Kaufman HE, Robin JB. Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis. Ophthalmology 1986; 93(10): 1310-1315.
59. Mutoh T, Ishikawa I, Matsumoto Y, Chikuda M: A retrospective study of nine cases of Acanthamoeba keratitis. Clin Ophthalmol 2010; 4: 1189-1192.
60. Bacon AS, Dart JK, Ficker LA, Matheson MM, Wright P. Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology 1993; 100(8): 1238-1243.
61. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea 2001; 20(1): 1-13.
62. Knickelbein JE, Hendricks RL, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidencebased review. Surv Ophthalmol 2009; 54(2): 226-234.
63. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev 2010(12):CD002898.
64. Pavan-Langston D, McCulley JP. Herpes zoster dendritic keratitis. Arch Ophthalmol 1973; 89(1): 25-29.
65. Kandori M, Inoue T, Takamatsu F, Hori Y, Maeda N, Tano Y. Two cases of Varicella zoster virus keratitis with atypical extensive pseudodendrites. Jpn J Ophthalmol 2009; 53(5): 548-549.
66. Pepose JS, Margolis TP, LaRussa P, Pavan-Langston D. Ocular complications of smallpox vaccination. Am J Ophthalmol 2003; 136(2): 343-352.
67. Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm Infect 2006; 82(2): 164-168.
68. Group HEDS. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med 1998; 339(5): 300-306.
69. Lilley CE, Carson CT, Muotri AR, Gage FH, Weitzman MD: DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc Natl Acad Sci USA 2005; 102(16): 5844-5849.
70. Remeijer L, Osterhaus A, Verjans G. Human herpes simplex virus keratitis: the pathogenesis revisited. Ocul Immunol Inflamm 2004; 12(4): 255-285.
71. Kaye S, Choudhary A. Herpes simplex keratitis. Prog Retin Eye Res 2006; 25(4): 355-380.
72. Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 1996; 37(12): 2485-2494.
73. Choong K, Walker NJ, Apel AJ, Whitby M. Aciclovir-resistant herpes keratitis. Clin Exper Ophthalmol 2010; 38(3): 309-313.
74. Gilbert C, Bestman-Smith J, Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat 2002; 5(2): 88-114.
75. Guess S, Stone DU, Chodosh J. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf 2007; 5(3): 240-250.
76. Sterk CC, Jager MJ, Swart-vd Berg M. Recurrent herpetic keratitis in penetrating keratoplasty. Doc Ophthalmol 1995; 90(1): 29-33.
77. Korb DR, Greiner JV, Glonek T. Tear film lipid layer formation: implications for contact lens wear. Optom Vis Sci 1996; 73(3): 189-192.
78. Ormerod LD, Smith RE. Contact lens-associated microbial keratitis. Arch Ophthalmol 1986; 104(1): 79-83.
79. Dart JK, Stapleton F, Minassian D. Contact lenses and other risk factors in microbial keratitis. Lancet 1991; 338(8768): 650-653.
80. McNamara NA, Fusaro RE, Brand RJ, Polse KA. Epithelial permeability reflects subclinical effects of contact lens wear. Br J Ophthalmol 1998; 82(4): 376-381.
81. Thakur A, Willcox MD. Contact lens wear alters the production of certain inflammatory mediators in tears. Exp Eye Res 2000; 70(3): 255-329.
82. Panda A, Sharma N, Das G, Kumar N, Satpathy G. Mycotic keratitis in children: epidemiologic and microbiologic evaluation. Cornea 1997; 16(3): 295-299.
83. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002; 86(11): 1211-1215.
84. Watson SL. Supurative keratitis. In: Evidence-based ophthalmology. Wormald R, Smeeth L, Henshaw K, Shah A, Eds. London, UK: BMJ Books 2004.
85. McClellan KA. Mucosal defense of the outer eye. Surv Ophthalmol 1997; 42(3): 233-246.
86. Stern GA, Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology 1991; 98(6): 847-853.
87. Srinivasan M, Lalitha P, Mahalakshmi R, et al. Corticosteroids for bacterial corneal ulcers. Br J Ophthalmol 2009; 93(2): 198-202.
88. Bharathi MJ, Ramakrishnan R, Meenakshi R, Padmavathy S, Shivakumar C, Srinivasan M. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol 2007; 14(2): 61-69.
89. Laspina F, Samudio M, Cibils D, et al. Epidemiological characteristics of microbiological results on patients with infectious corneal ulcers: a 13-year survey in Paraguay. Graefes Arch Clin Exp Ophthalmol 2004; 242(3): 204-209.
90. Hagan M, Wright E, Newman M, Dolin P, Johnson G. Causes of suppurative keratitis in Ghana. Br J Ophthalmol 1995; 79(11): 1024-1028.
91. Carmichael TR, Wolpert M, Koornhof HJ. Corneal ulceration at an urban African hospital. Br J Ophthalmol 1985; 69(12): 920-926.
92. Basak SK, Basak S, Mohanta A, Bhowmick A. Epidemiological and microbiological diagnosis of suppurative keratitis in Gangetic West Bengal, eastern India. Indian J Ophthalmol 2005; 53(1): 17-22.
93. Houang E, Lam D, Fan D, Seal D. Microbial keratitis in Hong Kong: relationship to climate, environment and contact-lens disinfection. Trans R Soc Trop Med Hyg 2001; 95(4): 361-367.
94. Fong CF, Tseng CH, Hu FR, Wang IJ, Chen WL, Hou YC. Clinical characteristics of microbial keratitis in a university hospital in Taiwan. Am J Ophthalmol 2004; 137(2): 329-336.
95. Rosa RH, Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 1994; 101(6): 1005-1013.
96. Ibrahim MM, Vanini R, Ibrahim FM, et al. Epidemiology and medical prediction of microbial keratitis in southeast Brazil. Arq Bras Oftalmol 2011; 74(1): 7-12.
97. Young RC, Hodge DO, Liesegang TJ, Baratz KH. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis. Arch Ophthalmol 2010; 128(9): 1178-1183.
98. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004; 15(4): 321-327.
99. Feist RM, Sugar J, Tessler H. Radial keratoneuritis in Pseudomonas keratitis. Arch Ophthalmol 1991; 109(6): 774-775.
100. Lee VH, Robinson JR: Topical ocular drug delivery. Recent developments and future challenges. J Ocul Pharmacol 1986; 2(1): 67-108.
101. Sirikul T, Prabriputaloong T, Smathivat A, Chuck RS, Vongthongsri A. Predisposing factors and etiologic diagnosis of ulcerative keratitis. Cornea 2008; 27(3): 283-287.
102. Balne PK, Nalamada S, Kodiganti M, Taneja M. Fungal keratitis caused by Chaetomium atrobrunneum. Cornea 2012; 31(1): 94-95.
103. Kotigadde S, Ballal M, Jyothirlatha, Kumar A, Srinivasa R, Shivananda PG. Mycotic keratitis: a study in coastal Karnataka. Indian J Ophthalmol 1992; 40(1): 31-33.
104. Poria VC, Bharad VR, Dongre DS, Kulkarni MV. Study of mycotic keratitis. Indian J Ophthalmol 1985; 33(4): 229-231.
105. Kisla TA, Cu-Unjieng A, Sigler L, Sugar J. Medical management of Beauveria bassiana keratitis. Cornea 2000; 19(3): 405-406.
106. Gingrich WD. Keratomycosis. JAMA 1962; 179: 602-608.
107. Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea 2002; 21(6): 555-559.
108. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol 1997; 81(11): 965-971.
109. Xuguang S, Zhixin W, Zhiqun W, Shiyun L, Ran L. Ocular fungal isolates and antifungal susceptibility in northern China. Am J Ophthalmol 2007; 143(1): 131-133.
110. Chander J, Sharma A. Prevalence of fungal corneal ulcers in northern India. Infection 1994; 22(3): 207-209.
111. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol 1980; 90(1): 38-47.
112. Imwidthaya P. Mycotic keratitis in Thailand. J Med Vet Mycol 1995; 33(1): 81-82.
113. Passos RM, Cariello AJ, Yu MC, Hofling-Lima AL. Microbial keratitis in the elderly: a 32-year review. Arq Bras Oftalmol 2010; 73(4): 315-319.
114. Hofling-Lima AL, Guarro J, Freitas D, et al. Clinical treatment of corneal infection due to Fonsecaea pedrosoi--case report. Arq Bras Oftalmol 2005; 68(2): 270-272.
115. Forster RK, Rebell G, Wilson LA. Dematiaceous fungal keratitis. Clinical isolates and management. Br J Ophthalmol 1975; 59(7): 372-376.
116. Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev 2000; 13(4): 662-685.
117. Rodriguez-Ares T, De Rojas Silva V, Ferreiros MP, Becerra EP, Tome CC, Sanchez-Salorio M. Acremonium keratitis in a patient with herpetic neurotrophic corneal disease. Acta Ophthalmol Scand 2000; 78(1): 107-109.
118. Yegneswaran PP, Pai V, Bairy I, Bhandary S. Colletotrichum graminicola keratitis: first case report from India. Indian J Ophthalmol 2010; 58(5): 415-417.
119. Kaliamurthy J, Kalavathy CM, Ramalingam MD, Prasanth DA, Jesudasan CA, Thomas PA. Keratitis due to a coelomycetous fungus: case reports and review of the literature. Cornea 2004; 23(1): 3-12.
120. Fernandez V, Dursun D, Miller D, Alfonso EC. Colletotrichum keratitis. Am J Ophthalmol 2002; 134(3): 435-438.
121. Polack FM, Kaufman HE, Newmark E. Keratomycosis. Medical and surgical treatment. Arch Ophthalmol 1971; 85(4): 410-416.
122. Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. Am J Ophthalmol 2008; 146(2): 260-265.
123. Al-Shakarchi F. Initial therapy for suppurative microbial keratitis in Iraq. Br J Ophthalmol 2007; 91(12): 1583-1587.
124. Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea 2008; 27(1): 22-27.
125. Doughman DJ, Leavenworth NM, Campbell RC, Lindstrom RL. Fungal keratitis at the University of Minnesota: 1971-1981. Trans Am Ophthalmol Soc 1982; 80: 235-247.
126. Thomas PA, Kuriakose T. Keratitis due to Arthrobotrys oligospora Fres. 1850. J Med Vet Mycol 1990; 28(1): 47-50.
127. Chowdhary A, Singh K. Spectrum of fungal keratitis in North India. Cornea 2005; 24(1): 8-15.
128. Grover S, Jagtap P, Sharma KD. Mycotic keratitis. Indian J Ophthalmol 1975; 23(2): 7-10.
129. Marcus L, Vismer HF, van der Hoven HJ, Gove E, Meewes P. Mycotic keratitis caused by Curvularia brachyspora (Boedjin). A report of the first case. Mycopathologia 1992; 119(1): 29-33.
130. Kunimoto DY, Sharma S, Reddy MK, et al. Microbial keratitis in children. Ophthalmology 1998; 105(2): 252-257.
131. Wilhelmus KR, Jones DB: Curvularia keratitis. Trans Am Ophthalmol Soc 2001; 99: 111-130; discussion 130-132.
132. Luque AG, Nanni R, de Bracalenti BJ. Mycotic keratitis caused by Curvularia lunata var. aeria. Mycopathologia 1986; 93(1): 9-12.
133. Guarro J, Akiti T, Horta RA, et al. Mycotic keratitis due to Curvularia senegalensis and in vitro antifungal susceptibilities of Curvularia spp. J Clin Microbiol 1999; 37(12): 4170-4173.
134. Thew MR, Todd B. Fungal keratitis in far north Queensland, Australia. Clin Experiment Ophthalmol 2008; 36(8): 721-724.
135. Vajpayee RB, Dada T, Saxena R, et al. Study of the first contact management profile of cases of infectious keratitis: a hospitalbased study. Cornea 2000; 19(1): 52-56.
136. Inoue N, Toshida H, Mamada N, Kogure N, Murakami A. Contact lens-induced infectious keratitis in Japan. Eye Contact Lens 2007; 33(2): 65-69.
137. Djalilian AR, Smith JA, Walsh TJ, Malech HL, Robinson MR. Keratitis caused by Candida glabrata in a patient with chronic granulomatous disease. Am J Ophthalmol 2001; 132(5): 782-783.
138. Schein OD, Ormerod LD, Barraquer E, et al. Microbiology of contact lens-related keratitis. Cornea 1989; 8(4): 281-285.
139. Hassan HM, Papanikolaou T, Mariatos G, Hammad A, Hassan H. Candida albicans keratitis in an immunocompromised patient. Clin Ophthalmol 2010; 4: 1211-1215.
140. Ahn M, Yoon KC, Ryu SK, Cho NC, You IC. Clinical aspects and prognosis of mixed microbial (bacterial and fungal) keratitis. Cornea 2011; 30(4): 409-413.
141. Guerra R, Cavallini GM, Longanesi L, et al. Rhodotorula glutinis keratitis. Int Ophthalmol 1992; 16(3): 187-190.
142. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Del Rev 2005; 57(11): 1595-1639.
143. Gugnani HC, Talwar RS, Njoku-Obi AN, Kodilinye HC. Mycotic keratitis in Nigeria. A study of 21 cases. Br J Ophthalmol 1976; 60(9): 607-613.
144. Gonawardena SA, Ranasinghe KP, Arseculeratne SN, Seimon CR, Ajello L. Survey of mycotic and bacterial keratitis in Sri Lanka. Mycopathologia 1994; 127(2): 77-81.
145. Anderson KL, Mitra S, Salouti R, Pham TA, Taylor HR. Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair. Cornea 2004; 23(5): 516-521.
146. Williams G, McClellan K, Billson F. Suppurative keratitis in rural Bangladesh: the value of gram stain in planning management. Int Ophthalmol 1991; 15(2): 131-135.
147. Coster DJ, Badenoch PR. Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. Br J Ophthalmol 1987; 71(2): 96-101.
148. Levey SB, Katz HR, Abrams DA, Hirschbein MJ, Marsh MJ. The role of cultures in the management of ulcerative keratitis. Cornea 1997; 16(4): 383-386.
149. Norina TJ, Raihan S, Bakiah S, Ezanee M, Liza-Sharmini AT, Wan Hazzabah WH. Microbial keratitis: aetiological diagnosis and clinical features in patients admitted to Hospital Universiti Sains Malaysia. Singapore Med J 2008; 49(1): 67-71.
150. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000; 107(8): 1497-1502.
151. Cheng KH, Leung SL, Hoekman HW, et al. Incidence of contactlens- associated microbial keratitis and its related morbidity. Lancet 1999; 354(9174): 181-185.
152. Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol 2010; 58(6): 497-507.
153. Saeed A, D'Arcy F, Stack J, Collum LM, Power W, Beatty S. Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in ireland. Cornea 2009; 28(3): 285-292.
154. Roussel TJ, Osato MS, Wilhelmus KR, Capnocytophaga keratitis. Br J Ophthalmol 1985; 69(3): 187-188.
155. Hirst LW, Harrison GK, Merz WG, Stark WJ. Nocardia asteroids keratitis. Br J Ophthalmol 1979; 63(6): 449-454.
156. Sanz-Marco E, Lopez-Prats MJ, Garcia-Delpech S, Udaondo P, Diaz-Llopis M. Fulminant bilateral Haemophilus influenzae keratitis in a patient with hypovitaminosis A treated with contaminated autologous serum. Clin Ophthalmol 2011; 5: 71-73.
157. Miedziak AI, Miller MR, Rapuano CJ, Laibson PR, Cohen EJ. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology 1999; 106(6): 1166-1170; discussion 1171.
158. Penland RL, Boniuk M, Wilhelmus KR. Vibrio ocular infections on the U.S. Gulf Coast. Cornea 2000; 19(1): 26-29.
159. Butt AA, Figueroa J, Martin DH. Ocular infection caused by three unusual marine organisms. Clin Infect Dis 1997; 24(4): 740.
160. Yu HS, Kong HH, Kim SY, Hahn YH, Hahn TW, Chung DI. Laboratory investigation of Acanthamoeba lugdunensis from patients with keratitis. Invest Ophthalmol Vis Sci 2004; 45(5): 1418-1426.
161. Walochnik J, Haller-Schober E, Kolli H, Picher O, Obwaller A, Aspock H. Discrimination between clinically relevant and nonrelevant Acanthamoeba strains isolated from contact lenswearing keratitis patients in Austria. J Clin Microbiol 2000; 38(11): 3932-3936.
162. McClellan K, Howard K, Niederkorn JY, Alizadeh H. Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci 2001; 42(12): 2885-2893.
163. Aitken D, Hay J, Kinnear FB, Kirkness CM, Lee WR, Seal DV. Amebic keratitis in a wearer of disposable contact lenses due to a mixed Vahlkampfia and Hartmannella infection. Ophthalmology 1996; 103(3): 485-494.
164. Thygeson P. Ocular viral diseases. Med Clin North Am 1959; 43: 1419-1440.
165. Pavlopoulos GP, Giannakos GI, Theodosiadis PG, Moschos MM, Iliakis EK, Theodosiadis GP. Rubeola keratitis: a photographic study of corneal lesions. Cornea 2008; 27(4): 411-416.
166. Ruben FL, Lane JM. Ocular vaccinia. An epidemiologic analysis of 348 cases. Arch Ophthalmol 1970; 84(1): 45-48.
167. Epstein RJ, Seedor JA, Dreizen NG, et al. Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival. Ophthalmology 1987; 94(8): 935-944.